TNNT2 and Schnyder corneal dystrophy: This observation suggests that a careful clinical evaluation associated with a simple and repeatable non-invasive tests determination of hs-cTnT plasma levels should represent the first step in the risk stratification for SCD, considering its ability to detect SSc patients at higher arrhythmic risk and therefore eligible for a comprehensive cardiac evaluations including 24h-ECG Holter.